Fulcrum Therapeutics Inc. (FULC) Tops Q1 EPS by 5c

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Backblaze (BLZE) call put ratio 12.9 calls to 1 put with a focus on July 12.50 calls as share price up 40%
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance